Internal Medicine, Endocrinology, Diabetes, & Metabolism · Dalton, GA
NPI
1093268138
Since 2016
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
475 Reed Rd Ste 104
Dalton, GA, 30720
Phone (706) 226-1622
Groups this clinician bills Medicare through
Medicare paid, 2024
$75K
2,297 services
Medicare patients, 2024
406
Average age 70
Drug cost, 2024
$3.0M
5,947 prescriptions
Company payments, 2025
$1,033
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Carlos A Penaherrera Oviedo was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 543 times for 318 patients. In total Carlos A Penaherrera Oviedo billed 2,297 services in 18 codes, and Medicare paid $75K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-02-16.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 543 | 318 | $12.46 | $6,766 |
| 99214 Office E&M - Established | Office | 486 | 290 | $88.68 | $43K |
| 82962 Clinical Chemistry | Office | 388 | 209 | $3.10 | $1,203 |
| 83036 Blood Count | Office | 264 | 168 | $9.12 | $2,409 |
| 36415 Venipuncture Blood Collection | Office | 259 | 181 | $8.25 | $2,138 |
| 95251 Test - Miscellaneous | Office | 159 | 93 | $25.34 | $4,029 |
| 99204 Office E&M - New | Office | 79 | 79 | $120.85 | $9,547 |
| 99211 Office E&M - Established | Office | 67 | 50 | $17.84 | $1,195 |
| 99215 Office E&M - Established | Office | 22 | 12 | $118.82 | $2,614 |
| 99213 Office E&M - Established | Office | 17 | 17 | $71.62 | $1,218 |
By year: 2022 $41K for 1,095 services; 2023 $42K for 1,142 services; 2024 $75K for 2,297 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82962 Clinical Chemistry | 388 | 209 | $3.10 | $1,203 |
| 83036 Blood Count | 264 | 168 | $9.12 | $2,409 |
| 36415 Venipuncture Blood Collection | 259 | 181 | $8.25 | $2,138 |
Medicare prescription drug claims, 2024
In 2024, the drug Carlos A Penaherrera Oviedo prescribed most often to Medicare patients was Ozempic (Semaglutide), with 513 prescriptions and refills. In total Carlos A Penaherrera Oviedo wrote 5,947 Medicare prescriptions that cost $3.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ozempic Semaglutide | 513 | 614 | 117 | $558K |
| Metformin Hcl Generic | 460 | 814 | 133 | $2,078 |
| Mounjaro Tirzepatide | 399 | 427 | 95 | $448K |
| Jardiance Empagliflozin | 388 | 541 | 99 | $313K |
| Levothyroxine Sodium Generic | 357 | 709 | 123 | $2,430 |
| Tresiba Flextouch U-200 Insulin Degludec | 275 | 453 | 97 | $251K |
| Farxiga Dapagliflozin Propanediol | 180 | 234 | 53 | $132K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 180 | 331 | 68 | $20K |
| Trulicity Dulaglutide | 169 | 208 | 43 | $201K |
| Metformin Hcl Er Metformin Hcl | 156 | 324 | 67 | $1,424 |
| Novolog Flexpen Insulin Aspart | 149 | 244 | 66 | $27K |
| Pioglitazone Hcl Generic | 145 | 237 | 35 | $544 |
| Methimazole Generic | 124 | 184 | 32 | $1,296 |
| Tresiba Flextouch U-100 Insulin Degludec | 120 | 223 | 45 | $62K |
| Atorvastatin Calcium Generic | 95 | 186 | 36 | $427 |
Brand drugs: 3,653 claims; generic drugs: 1,831 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Carlos A Penaherrera Oviedo $1,033 ($1,033 in general payments such as food, travel and fees) from 15 companies. The largest payer was Medtronic, Inc. with $192.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.